What this division covers
This is the supplement and nutrition side of the business, kept deliberately separate from the medicine portfolio because the two follow different regulatory routes. A buyer who arrives here is usually deciding one of three things: whether to source a bulk ingredient, whether to buy a finished supplement under their own label, or whether the product they intend to sell is in fact a medicine in their market and therefore cannot be handled as a supplement at all.
The range splits into two families with different evidence bases:
- Vitamins, minerals and clinical nutrition — the nutrients that appear on the WHO Model List of Essential Medicines, in defined strengths and dosage forms, used to treat or prevent deficiency and in parenteral nutrition. These sit closest to the medicine portfolio. Vitamins & minerals range
- Functional nutrients — collagen, biotin, levocarnitine, glutathione, coenzyme Q10 and body-fitness ingredients. These are supplied as food supplements or nutraceutical ingredients and carry no therapeutic indication. Functional nutrient range
What the published guidance says
- The Model List sections that carry this portfolio Vitamins and minerals sit in section 27 of the 24th WHO Model List (2025). The listings include ascorbic acid, cholecalciferol and ergocalciferol, iodine, nicotinamide, pyridoxine and retinol, alongside calcium and other minerals. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- Anaemia prevention is a listed intervention Ferrous salt with folic acid appears on the Model List as an antianaemia medicine, in tablet form. Folic acid and iron are the standard pair used in national supplementation programmes, and matching your market's programme strength matters. WHO — Essential medicines (fact sheet)
- Genuine supplement ingredients are outside the Model List by design. Collagen, biotin and coenzyme Q10 have no therapeutic listing, so they cannot be described in promotional material as treating any condition. Copy written for one market is frequently unlawful in another, because permitted health-claim lists differ. WHO — Essential medicines (fact sheet)
Manufacturing and containment
Supplement production runs in dedicated facilities with their own equipment train, separate from the sterile and medicine lines, so that allergen, cross-contamination and cleaning-validation questions have a clean answer during a supplier audit. Batch records, in-process checks and finished-product testing follow the same quality system used elsewhere in the company.
- Bulk ingredients — powder and granulate in fibre drum or food-grade lined carton, with particle size distribution stated.
- Direct-compression and capsule grades — flow and compressibility characterised so the ingredient runs on your press or capsule filler.
- Premixes and custom blends — multi-component blends to a stated assay, with blend homogeneity data in the release file.
- Finished supplements — tablets, hard capsules, effervescent and chewable tablets, sachets, oral liquids and drops, under your own artwork where the destination rules allow.
Testing and documentation
Every batch is released on a certificate of analysis naming the assay method and the limits applied. Release testing typically covers assay and identification, heavy metals and elemental impurities, microbiological limits, water content and ash, residual solvents where the process uses one, and particle size distribution for powder grades. Allergen, GMO and origin declarations are issued where the material is used in a supplement formulation.
Regulatory position: supplement or medicine
The same nutrient can be a food supplement in one country and a registered medicine in another. Before quoting we ask for the destination market and the claim position you intend to take, because that decides which of the following applies — and, in some cases, whether the label must be rewritten rather than translated:
- Food supplement or nutraceutical notification
- Ingredient-level dossier with safety and stability data
- Label and health-claim review against the destination rules
- Import permit, free-sale certificate and certificate of origin
- Full CTD route, where a therapeutic indication puts the product into the medicine category in your market
Questions buyers ask
Can you manufacture a supplement under our own brand?
Yes. Private-label and customer-brand production is standard, with artwork supplied in English, Arabic, French, Russian or Spanish. Where the destination labelling rules require the manufacturer to be named on the pack, the wording is agreed before the first print run.
What is the difference between this range and your medicines range?
Regulatory route. The medicines range covers products with therapeutic indications, released against pharmacopoeial monographs and supported by a CTD dossier. This range covers nutrients sold as supplements or ingredients, with claim language set by the destination market.
Do you supply the raw ingredient as well as the finished supplement?
Yes. Bulk powder and granulate, direct-compression and capsule grades, premixes, and finished tablets, capsules, sachets and liquids are all available from the same quality system.
Which documents ship with each batch?
Certificate of analysis, specification, method of analysis, allergen and origin statements, GMP certificate, and the safety data sheet where the material requires one.
Explore this division
Vitamins, minerals & clinical nutrition · Functional nutrients · Full product catalogue · Request a quotation
Reference information only. Published guidance is quoted for professional and regulatory-context purposes and is not medical advice or a prescribing recommendation.
